Science Explorer Interactive view Map
Topic · Rheumatology

Osteomyelitis and Bone Disorders Research

Osteomyelitis and Bone Disorders Research is a research topic within Rheumatology. Science Explorer counts 7.6k research works in it since 1950. 9.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the clinical, genetic, and therapeutic aspects of autoinflammatory bone disorders, including chronic recurrent multifocal osteomyelitis (CRMO), synovitis acne pustulosis hyperostosis osteitis (SAPHO) syndrome, and non-bacterial osteomyelitis. It explores the role of genetic mutations, the efficacy of biological therapies such as pamidronate, and the use of advanced imaging techniques in diagnosis and management.

  • Autoinflammatory Bone Disorders
  • Chronic Recurrent Multifocal Osteomyelitis
  • Synovitis Acne Pustulosis Hyperostosis Osteitis Syndrome
  • SAPHO Syndrome
  • Non-Bacterial Osteomyelitis
  • Inflammatory Bowel Disease
  • Genetic Mutations
  • Biological Therapy
  • Imaging Techniques
  • Pamidronate Treatment
Research works
7.6k
fractional, since 1950
In the world top 10%
707
per year above
Top-10% rate
9.3%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+29%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Osteomyelitis and Bone Disorders Research research?

By volume, China and the United States publish the most (198 and 191 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 198 works
  2. 2 United States 191 works
  3. 3 India 109 works
  4. 4 Japan 91 works
  5. 5 Germany 64 works
  6. 6 United Kingdom 56 works
  7. 7 France 50 works
  8. 8 Türkiye 49 works
  9. 9 Brazil 44 works
  10. 10 Italy 42 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 22.2%United States: 21.4%India: 12.1%Japan: 10.2%6 others listed: 34.2%22%largest
China198 · 22.2%United States191 · 21.4%India109 · 12.1%Japan91 · 10.2%6 others listed306 · 34.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Osteomyelitis and Bone Disorders Research research?

By volume in 2022–2025, Beijing University of Chinese Medicine publishes the most Osteomyelitis and Bone Disorders Research research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Peking Union Medical College Hospital.

By volume, 2022–2025

  1. 1 Beijing University of Chinese MedicineChina 7 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 6 works
  3. 3 Peking Union Medical College HospitalChina 5 works
  4. 4 Leiden University Medical CenterNetherlands 5 works
  5. 5 Hacettepe UniversityTürkiye 5 works
  6. 6 All India Institute of Medical SciencesIndia 5 works
  7. 7 Universidade de São PauloBrazil 4 works
  8. 8 Peking UniversityChina 4 works
  9. 9 Wuhan UniversityChina 3 works
  10. 10 Stomatology HospitalChina 3 works

Where is Osteomyelitis and Bone Disorders Research research done?

The largest centres of Osteomyelitis and Bone Disorders Research research in 2022–2025 are Beijing (China), Paris (France), Tokyo (Japan) and Moscow (Russia).

Largest cities, 2022–2025

  1. 1 Beijing China 36 works
  2. 2 Paris France 18 works
  3. 3 Tokyo Japan 18 works
  4. 4 Moscow Russia 18 works
  5. 5 London United Kingdom 17 works
  6. 6 Shanghai China 15 works
  7. 7 São Paulo Brazil 14 works
  8. 8 Ankara Türkiye 13 works
  9. 9 Hangzhou China 13 works
  10. 10 Guangzhou China 12 works
See Osteomyelitis and Bone Disorders Research on the map

Is Osteomyelitis and Bone Disorders Research research growing?

Output in 2018–2022 was 29% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Osteomyelitis and Bone Disorders Research.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.